The World Health Organization (WHO) on Friday announced it has granted emergency approval to the India-manufactured coronavirus vaccine Covovax.
The jab, produced by Serum Institute of India under licence from the US-based Novavax, will now be distributed as part of global vaccine-sharing system Covax, "giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries", WHO said in a statement.
"Even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2," said Mariangela Simao, the WHO's access to vaccines chief.
"This listing aims to increase access particularly in lower-income countries, 41 of which have still not been able to vaccinate 10 percent of their populations, while 98 countries have not reached 40 percent," she said.
Covovax requires two doses and is stable at 2 to 8 degrees Celsius refrigerated temperatures.
WHO Members' Pandemic Accord Talks To Spill Into 2025 How This Mpox Outbreak Is Different, According To Experts WHO Says Droplets A Minor Route Of Mpox Spread. What We Know So Far Ashneer Grover's LinkedIn Post After Salman Khan Schools Him On Bigg Boss What Canada Police Said On Indian-Origin Woman's Death Inside Walmart Oven Why Donald Trump's Cabinet Choices Are Giving Pakistan Sleepless Nights Rahul Gandhi Shares Photo With Indira Gandhi On Her Birth Anniversary "Escalating War": Trump's Allies Slam Biden Over Missiles For Ukraine Domestic Air Passenger Traffic Crosses 5.05 Lakh Mark On November 17 Track Latest News Live on NDTV.com and get news updates from India and around the world.